A Synergistic Approach to Cancer Immunotherapy
A Synergistic Approach to Cancer Immunotherapy
What is Co-Activated Cell Therapy?
Co-Activated Cell Therapy is an advanced immunotherapy that combines two powerful approaches—Dendritic Cell (DC) Therapy and Lymphocyte Activated Killer (LAK) Cell Therapy—administered together in a single infusion. This dual strategy is designed to deliver both targeted and broad-spectrum anti-cancer activity. By uniting the precision of dendritic cells with the immediate cytotoxic strength of LAK cells, Co-Activated Cell Therapy offers patients a synergistic treatment that enhances tumor clearance and strengthens long-term immune defense.
How the Therapy is Developed
The process begins with the collection of immune cells from the blood of the patient. In our cGMP-compliant, ISO-certified laboratory, two parallel preparations are carried out. Monocytes are differentiated into dendritic cells and pulsed with tumor-specific antigens to train them to recognize cancer. At the same time, lymphocytes are cultured with interleukin-2 (IL-2) to generate Lymphocyte Activated Killer cells, which develop enhanced tumor-killing capabilities. These two populations—antigen-loaded dendritic cells and activated LAK cells—are prepared simultaneously under strict quality controls to preserve their potency.
How It Works in the Body
Once ready, both cell populations are infused back into the patient at the same time. The dendritic cells migrate to lymph nodes, where they present tumor antigens and activate tumor-specific cytotoxic T lymphocytes. In parallel, the LAK cells circulate immediately through the bloodstream, exerting direct cytotoxic effects on malignant cells through perforin- and granzyme-mediated apoptosis. The simultaneous infusion creates a powerful synergy: dendritic cells initiate and guide precise immune responses, while LAK cells provide immediate tumor debulking and immune stimulation. This coordinated activity promotes both short-term tumor destruction and long-term immune memory.
Integrated Cancer Care at Oasis of Hope
At Oasis of Hope Cancer Center, Co-Activated Cell Therapy reflects our philosophy of combining therapies for maximum patient benefit. By infusing dendritic cells and LAK cells together, we amplify both specificity and strength within a single treatment. This therapy is further integrated into personalized treatment plans that may include metabolic therapies, nutritional programs, and additional immunotherapies such as Natural Killer (NK) Cell Therapy or Tumor Infiltrating Lymphocyte (TIL) Therapy. The result is a comprehensive approach designed not only to fight cancer aggressively but also to support the patient’s overall well-being and long-term recovery.
Become a Patient
Take the first step toward personalized, integrative cancer care designed around your unique needs. Connect with our team today to explore your options and begin your journey with Oasis of Hope.






